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Original Article
Abstract
Purpose: To study the clinical outcome and scope of laparoscopic management in patients of cancer stomach. Methods: This is a
prospective study of our first 25 patients of cancer stomach managed laparoscopically. Following procedures were undertaken:
1) Gastric resection in resectable cases; 2) Palliative bypass; 3) Tumor/ nodal/ peritoneal/ any other/ biopsy in cases of unresec-
table tumors. Results: Growth was resectable in 10 (40%) patients, and unresectable in 15 (60%) patients. Diagnostic laparosco-
py had sensitivity of 100%, while other modalities of investigation were not totally useful in 1/3 to ½ of cases. Laparoscopic
gastrojejunostomy was done in 5 (20%) patients, laparoscopy assisted distal partial gastrectomy was performed in 8 (32%) pa-
tients while totally laparoscopic gastrectomy was possible in 1 (4%) patient. Long term follow up was observed. Conclusion: In
cancer stomach laparoscopy is a safe, effective, and cost effective means of directing appropriate therapy especially in patients
requiring diagnostic, staging and palliative procedures.
Keywords:Diagnostic Laparoscopy; Laparoscopic Gastrojejunostomy; Laparoscopic Gastrectomy; Unresectable Tumors; Pallia-
tion; Laparoscopic Biopsy
Introduction
Gastric cancer is one of the leading causes of death from
malignant diseases in India (Nandakumar et al.).1 It was Ki-
tano et al. 2 who first described treatment for early gastric
cancer by laparoscopy-assisted distal gastrectomy (LADG).
Gastric resection with D1 lymphadenectomy with no residu-
al neoplasm remains the gold standard treatment for cancer
stomach, as it is the only treatment modality offering the
possibility of cure for these patients.3, 4, 5, 6 Correct staging is a
prerequisite for the optimal treatment. Despite an increas-
ingly sophisticated diagnostic armamentarium many patients
with gastric malignancy continue to have the diagnosis of
unresectable or metastatic disease made at exploratory lapa-
rotomy. Laparoscopic surgery is sensitive for staging gastric
cancer especially identifying tumor deposits that cannot be
detected by conventional imaging.7 It can thus prevent open
surgery in patients with inoperable disease. Gastric outlet
obstruction is a common and often preterminal event for
patients with inoperable neoplasms of the distal stomach.
Palliative laparoscopic gastric bypass is best that can be done
for such patients.
The objective of this study is to assess the role of laparoscopy
in gastric malignancies in our setup with the changing trends
of treatment without compromising the surgical principles
and maintaining high standards of patient care.
Methods and Materials
Follow up of our first of 25 patients of cancer of stomach
who were managed laparoscopically is presented. A de-
tailed work up was carried out and recorded on a profor-
ma. A written informed consent was taken from every
patient. Preoperative preparation was carried out by giv-
ing bowel washes 24-48 hours before surgery. The patients
were placed in a reverse Trendelenburg position.
In earlier cases the surgeon stood on the right side of the
patient at the start of surgery, and during dissection of the
infrapyloric lymph nodes moved to the left side of the
patient, later the most comfortable situation was seen to
be standing in between the legs. Carbon dioxide (Co2)
pneumo peritoneum of 15mm Hg was created by using
closed Veress needle technique as a uniform standard pro-
cedure. 10 mm 0o laparoscope (later on 30o) was intro-
duced through the infraumblical port. Working ports were
made in the right and left lumbar regions, right and left
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sub-costal regions. Additional ports were placed for re-
traction of liver and stomach and wherever needed. The
abdomen was surfed thoroughly for growth, abdominal
viscera, nodes metastasis and for ascitis. Following proce-
dures were undertaken: 1) Gastric resection in resectable
cases; 2) Palliation by bypass procedures with or without
biopsies, ascetic sampling; 3) Tumor/nodal/peritoneal /any
other biopsy in case of unresectable tumors, not amenable
to palliative bypass procedures.
The dissection was carried out by diathermy and ultrascis-
sion. The transaction and anastomosis was carried out by 45
mm and 65 mm endostaplers and Circular and linear cutter
staplers. The specimens were inserted into a retrieval bag,
withdrawn through the 10/12 mm port widened to accom-
modate. Specimen orientation was done by sutures and was
sent for histopathological examination. The extracorporeal
anastomosis also were done using window.
Results
There were 19 (76%) males as against females 6 (24%).
Males: Female ratio was 3.17:1. The youngest patient was 30
years old female and oldest was 84 years old male. The mean
age was 59.8 years. The highest incidence was in the 51-70
years (72%). Out of 6 females 4 were in the age group of
21-40 years. Cancer stomach was seen in younger age group
among females. Pain was the predominant symptom in 14
(56%) of patients despite the fact that dyspepsia and sour
eructations were the commonest symptom. Pain was fol-
lowed by anorexia (12%) and vomiting (8%) as the predom-
inant symptom. Though pain was present in 18 (72%) pa-
tients, pain associated with vomiting was seen in 15 patients
(60%), while the combination of pain, vomiting, weight loss
was present in 13 patients (52%), and the combination of
pain, vomiting, anorexia, weight loss was seen in 12 patients
(48%) patients.
The site of pain was epigastrium in 16 patients, while 2 pa-
tients presented with pain in the right hypochondrium. The
radiation of pain was seen in 4 patients. The character of
pain was burning in 11 and dull ache in 6 patients. The stab-
bing pain was present in 1 patient; change in character of
pain was seen in 4 patients. At the mean duration of pain
was 7.4 months. The mean duration of symptoms were 7.34
months. Anemia was the most common co morbid condition
accounting for 16 (64%) cases, followed by COPD in 6
(24%).
One patient had gastrojejunostomy done for peptic ulcer 20
years back. 3 patients (12%) had history of gastric ulcer
while 1 had duodenal ulcer and 2 had history of removal of
gastric polyps. All patients were non-vegetarians, 12 (48%)
were alcoholic, 18 (72%) were smokers, 7 (28%) were non-
smokers. Blood group A+ve was the most common being pre-
sent in 11 (44%), followed by O+ve which was seen in 7(28%).
Site of carcinoma of stomach was distal one third in 15 (60%)
patients, proximal one third in 3(12%) patients, middle one
third in 2 (8%) and diffuse involvement was seen in 5 (20%)
patients [Table 1].
Regional metastasis was present in 6 (24%) patients; perigas-
tric lymph nodes were present in 17 (68%) patients, ascitis in
10 (40%) patients. Intraoperative complications were present
in 7 (28%) patients 1 (4%) patient had intra operative hem-
orrhage while 6 (24%) had technical complications.
Post-operative complications were present in 11 (44%).
TABLE 1: Showed demographic details.
Predominant symptom Number of patients Percentage (%)
Sex
Males 19 76%
Females 6 24%
Pain (predominant symptom) 14 56%
Site of growth
(Diagnostic laparoscopy)
Proximal 1/3 3 12%
Middle 1/3 involving pylorus 2 8%
Distal 1/3 15 60%
Diffuse involvement 5 20%
Extent of growth
Perigastric lymphadenopathy 17 68%
Regional lymphadenopathy 6 24%
Ascites 10 40%
Histopathology
Moderately differentiated
adenocarcinoma stomach
20 80%
Poorly differentiated adeno-
carcinoma stomach
5 20%
Diagnostic laparoscopy had sensitivity of 100%, while other
modalities of investigation missed 1/3 to ½ of cases. Endos-
copy had a sensitivity of 64.28%, while endoscopic biopsy
was having sensitivity of only 28.57%. Growth was resec-
table in 10(40%) patients, while in 15(60%) it was unresec-
table [Table 2], [Figures 1, 2].
Long term results
Of the total 25 patients, 20 (80%) were followed up and 5
were lost to follow-up. Follow-up data were available for 20
(80%) of patients treated laparoscopically. The mean fol-
low-up was 60 months (range 6-72 months).
In the follow up 3 (15%) patients experienced recurrence and
died due to the disease within 12 months. Two patients are
still alive at 70 months after surgery. Five patients died at 14
months and 9 patients died at 18 months and one patient died
in the immediate postoperative period.
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TABLE 2: Showed various procedures done.
Procedure done Number of patients
Diagnostic laparoscopy and biopsy/ascetic sampling 4 (16%)
Diagnostic laparoscopy followed by laparoscopic gastrojejunostomy 5 (20%)
Diagnostic laparoscopy followed by laparoscopy converted into open gastrojejunostomy 6 (24%)
Diagnostic laparoscopy followed by laparoscopic gastrectomy with perigastric lymphadenectomy 1 (4%)
Diagnostic laparoscopy followed by laparoscopy converted into open oesophagogastrectomy with
perigastric lymphadenectomy 1 (4%)
Diagnostic laparoscopy followed by laparoscopic partial gastrectomy with perigastric lymphadenec-
tomy with trans thoracic oesophagogastrectomy
1 (4%)
Diagnostic laparoscopy followed by laparoscopy assisted partial gastrectomy with peri gastric lym-
phadenectomy 6 (24%)
Diagnostic laparoscopy followed by laparoscopy assisted total gastrectomy with peri gastric lym-
phadenectomy with oesophagojejunostomy 1 (4%)
FIG. 1: Showing various findings on diagnostic laparoscopy.
FIG. 2: Showing site of gastrojejunostomy with intracorporial repair.
Discussion
Generally extent of surgery was determined by tumor stage,
tumor location, and histological type, according to Lauren
classification, quality of life, age and expected survival. Few
randomized clinical trials 3, 4, 5, 6 have compared open distal
gastrectomy versus laparoscopic operation, in which the
entire dissection is conducted laparoscopically, followed by
specimen removal through small incision in epigastrium and
Billroth I reconstruction. In our cases the critical questions of
important clinical consequences for the outcome of the pa-
tient with advanced but potentially curable gastric cancer
are among the following options: (1) Subtotal vs. total gas-
trectomy; (2) spleen preservation vs. splenectomy; (3)
preservation of pancrease vs. left sided pancreatectomy; (4)
limited D1 vs. extended D2/D3 lymphadenectomy.
Total gastrectomy is the procedure of choice for tumors lo-
cated in the proximal or middle third of the stomach, ad-
vanced intestinal type carcinoma and for all carcinomas cat-
egorized as diffuses according to the Lauren classification.
For antral cancers, subtotal gastrectomy with the advantage
of better quality of life and a low morbidity.8 Griffith et al.9
suggest that indications for splenectomy are (1) direct inva-
sion of the spleen through serosa and (2) enlarged suspected
hilar lymph nodes.
The well documented significant adverse effect of pancre-
atectomy on morbidity and mortality and the available his-
tological and survival data make it clear that the only indica-
tion for this procedure is direct invasion of the pancreas by
the tumor through the gastric serosa, however resection of
the distal pancreas has proved to be very dangerous.10 Some
studies have described the disadvantages of laparoscopic
assisted distal gastrectomy compared to open distal gastrec-
tomy, which include increased operative time similar to that
in our study.11-14 The most and at the same time, controver-
sial topic in the surgical management of gastric carcinoma is
the extend of lymphadenectomy. D2/D3 resection has been
performed for more than 30 years in Japan, but the thera-
peutic benefit of this procedure still remains debatable. Ac-
cording to the JRSGC (Japanese Research Society for Gastric
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Cancer) guidelines, the upper abdominal lymph nodes are
grouped into 16 stations, which are subsequently divided
into four levels (NI-N4) according to the location of the pri-
mary tumor.15 The extent of the lymphadenectomy is classi-
fied according to the level of lymph node dissection (D1 to
D2). On the basis of these reasons we decide to go for subto-
tal /total gastrectomy, spleen preservation and preservation
of the pancreas with limited D1/D2 resection.
Of the various procedures performed in our study, palliation
was the most common and was done in the form of gastro-
jejunostomy. Mostly laparoscopic gastrojejunostomy was
done in 5 (20%) patients. In 6 (24%) patients conversion into
open was done to complete the procedure. Diagnostic lapa-
roscopy avoided laparotomy in 4 (16%) and was better in
accurately assessing the serosal infiltration, peritoneal seed-
ing, and metastasis and allowed the surgeon to choose more
effective treatment modality. According to Burke et al.16
laparoscopy avoided laparotomy in 23.1% cases, Molloy et al.
17 in 42.2% cases.
In our study intraoperative complications occurred in 7
(28%) patients. 1(4%) patient had intraoperative hemor-
rhage, bleeding from the left gastric artery, 6 (24%) patients
had technical complications in the form of instrumentation
failure.
Post-operative complications were seen in 11 (44%) cases. In
all the cases of postoperative, wound infection were present
4 (16%), it was preceded by seroma formation 9 (36%).
One patient in the laparoscopy Assisted gastrectomy group,
on 4th postoperative day, started pouring bile from the drain
kept in the right paracolic gutter. This drainage stopped
spontaneously within another five days with no evidence of
continuous or residual leak. No patient developed complica-
tions related to pneumoperitoneum or anesthesia or the ones
like pancreatitis, pleural effusion, dumping syndrome, in-
trabdominal abscess or external bleeding.
In our study the percentage of conversion into open surgery
taking into account all the procedures was 28% compared to
1-2% reported by Gemmill et al.18 The two studies are not
comparable as the total number of cases in our series is very
low. Mean operating time, mean intraoperative blood loss,
pain, mean analgesic doses, mean time to pass flatus, time to
start liquid diet (resumption of diet), time to become fully
mobile was least in case of laparoscopy group. Mean postop-
erative hospital stay was lesser in those who underwent lap-
aroscopic gastrojejunostomy than others [Table 3]. Our re-
sults were similar and sometimes better than a number of
studies conducted all over the world especially in the west
Pugliese et al.19, Dulucq et al. 20, Adachi et al.21, Sakuramoto
et al. 22
Histologically the growth was moderately differentiated
adenocarcinoma in 20 (80%) patients and poorly differenti-
ated adenocarcinoma stomach in 5 (20%). The margins of
resection were 4-6 cm and these were found to be free of
tumor. Of total patients 8 (32%) were in T2 N0 M0, 2 (8%)
patients in stage T2 N1 M0 and 15 (60%) patients were in T4
NX M0/M1 stage. In our study lymph node metastasis was
seen in 20% of the patients who underwent gastrectomy
while lymph node metastasis was absent in 80% of cases
which corresponds to the study done by Kitano et al.22 Con-
dition on discharge in 20 (80%) patients was satisfactory.
In all the patients in whom growth was unresectable and
palliative laparoscopic gastrojejunostomy was performed
were tolerating oral diet reasonably well and their agonies
were less and recovery was faster as compared to the open
group. All the patients were followed up for 3 weeks after
discharge and all of them in the laparoscopy group were
doing reasonably far better than the open group except for
one patient who underwent laparoscopic gastrojejunostomy
was readmitted for gross ascitis.
Postoperative mortality was present in 1 (4%) patient (with-
in 1 week from the discharge). In the study done by Gemmil
et al.18 who studied 2546 patients, postoperative mortality
was 0.1% of cases. The difference in value was due to our
small sample size.
Conclusion
Our experience suggests that laparoscopy is a safe, effective
and cost-effective means of directing appropriate therapy
and avoiding unnecessary exploration. Laparoscopy plays an
extremely valuable role in staging of patients with gastric
malignancy. Palliative laparoscopic gastric bypass in compar-
ison to open bypass has less operation time, significantly less
intraoperative blood loss and least incidence of wound infec-
tion.
Laparoscopy assisted gastrectomy, when compared with
conventional open gastrectomy, has several advantages, in-
cluding less surgical trauma, less pain, rapid return of gas-
trointestinal function, less impaired nutrition, and shorter
hospital stay, with no decrease in operative curability. When
performed by a skilled surgeon, laparoscopic assisted gas-
trectomy is safe, useful and curative technique for patients
with gastric cancer. Compared to conventional surgery, it
offers the advantages of low invasiveness and improved
quality of life. Lastly there are definite benefits of laparos-
copy in diagnosis, staging and palliation in case of carcinoma
stomach.
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